Sphs stock price target smnredt

Sphs stock price target

17.01.2021

Fradette36543

Online Stock Comparison - Compare Sophiris Bio, Inc. (SPHS) to four other stocks with NASDAQ.com's stock comparison tool. SOPHIRIS BIO INC (SPHS) Stock Price, Quote, History & News ... Sophiris Bio Announces Nasdaq Delisting. Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the treatment of patients with urological diseases, today announced that on March 10, 2020, the Nasdaq Office of General Counsel notified the Company that the SPHS Stock Quote - Sophiris Bio Inc. Price - Nasdaq Stock quote for Sophiris Bio Inc. Common Stock (SPHS) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. Time and Sales - Intraday Stock Last Price History for ... Mar 27, 2020 · NASDAQ Last Sale (NLS) Intraday Stock History Report: Time and sales data for Sophiris Bio Inc. (SPHS)

SPHS Price Target | Sophiris Bio Stock Forecast & Ratings

Is A Downturn Overdue? Provention Bio Inc. (NASDAQ:PRVB ... Mar 12, 2020 · Their price target on the stock stands at $5. Rodman & Renshaw also rated SPHS as Initiated on March 13, 2017, with its price target of $6 suggesting that SPHS could surge by 92.92% from its current share price. Even though the stock has been trading at $0.58/share, analysts expect it to down by -60.30% to reach $3.25/share. Sophiris Bio, Inc. (SPHS) stock price, quote, history ...

Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.

Sophiris "worth sticking with" - Piper - Sophiris Bio, Inc ... Jun 26, 2018 · Piper Jaffray maintains Overweight rating and $7 price target on Sophiris Bio (NASDAQ:SPHS) following disclosure of Phase 2b topsalysin data in localized prostate cancer. Implied upside 111%.While a p Sophiris Bio (NASDAQ:SPHS) Stock Price Down 15.4% ... An increase of 42% from the average daily volume of 1,359,925 shares. The stock had previously closed at $0.78. Several brokerages have recently commented on SPHS. HC Wainwright set a $2.80 target price on shares of Sophiris Bio and gave the company a “buy” rating in a report on Monday, October 21st. Are Sophiris Bio, Inc. (SPHS) Shares Headed For A Pullback ... Jan 13, 2020 · On Friday, shares of Sophiris Bio, Inc. (NASDAQ:SPHS) marked $0.53 per share versus a previous $0.63 closing price. With having a -16.10% loss, an insight into the fundamental values of Sophiris Bio, Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock charts.

Sophiris Bio (NASDAQ: SPHS) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. Date, Research Firm, Action, Current, Target

SOPHIRIS BIO INC (SPHS) Analyst Ratings, Estimates ...

CPRX Price Target | Catalyst Pharma Stock Forecast & Ratings

Find the latest SOPHIRIS BIO INC (SPHS) stock quote, history, news and other vital information to help you with your stock trading and investing. Fair Value is the appropriate price for the SPHS Sophiris Bio Inc. — Stock Price and Discussion ... Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. Sophiris Bio Inc. (SPHS) Stock Quotes | Nasdaq Mar 14, 2019 · Sophiris Bio Inc. (SPHS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. SPHS - Sophiris Bio Inc Stock quote - CNNMoney.com